Clinical trials: Soy Allergy

Food Allergy

ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults

• Completed
• Age: 4 to 55 years
• Phase 1/2
• Results posted

The purpose of this study is to assess the efficacy and safety of ADP101 in food allergic children and adults.

Trial name

NCT04856865

Testing

Low dose ADP101, High dose ADP101

Where

15 sites in United States

Volunteers

73 people

Sponsor

Alladapt Immunotherapeutics, Inc.